Actionnariat et activité des initiés pour Pulmonx Corporation (LUNG): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.98 |
| Capitalisation | $84M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-01 | French Glendon E. III | S-Sale | 4,098 | $9K |
| 2026-09-01 | French Glendon E. III | S-Sale | 37,784 | $85K |
| 2026-09-01 | Radhakrishnan Srikanth | S-Sale | 2,643 | $6K |
| 2026-09-01 | Radhakrishnan Srikanth | S-Sale | 2,121 | $5K |
| 2026-09-01 | Radhakrishnan Srikanth | S-Sale | 3,618 | $8K |
| 2026-09-01 | Radhakrishnan Srikanth | S-Sale | 5,863 | $13K |
| 2026-09-01 | Lehman David Aaron | S-Sale | 3,807 | $9K |
| 2026-09-01 | Lehman David Aaron | S-Sale | 2,224 | $5K |
| 2026-09-01 | Lehman David Aaron | S-Sale | 3,476 | $8K |
| 2026-09-01 | Lehman David Aaron | S-Sale | 4,827 | $11K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $4.1M | $14.8M | $231.8M | $148.5M | $101.7M | $83.5M | $70.9M | $70.0M |
| Placements à Court Terme | 0 | $13.6M | 0 | $31.6M | $39.4M | $33.6M | $30.6M | 0 |
| Créances | $3.4M | $6.0M | $4.6M | $6.9M | $9.3M | $13.0M | $13.8M | $12.1M |
| Stocks | $3.3M | $5.6M | $10.7M | $16.3M | $14.6M | $16.7M | $16.9M | $15.8M |
| Actifs Courants | $11.3M | $41.1M | $250.0M | $208.0M | $169.0M | $150.4M | $136.2M | $101.7M |
| Immobilisations Corporelles | $375000 | $7.5M | $10.4M | $12.9M | $10.5M | $7.4M | $21.5M | $20.2M |
| Goodwill | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M |
| Actifs Incorporels | $647000 | $524000 | $400000 | $277000 | $154000 | $31000 | 0 | $700000 |
| Actifs Totaux | $15.0M | $53.5M | $263.7M | $235.2M | $193.7M | $177.8M | $162.8M | $129.3M |
| Dettes Fournisseurs | $1.3M | $2.7M | $1.5M | $1.6M | $1.8M | $1.5M | $3.8M | $3.9M |
| Dette à Court Terme | 0 | 0 | $2.2M | $91000 | $90000 | $2.2M | $3.2M | $1.3M |
| Passifs Courants | $8.1M | $14.2M | $12.5M | $17.6M | $18.5M | $23.2M | $24.4M | $20.1M |
| Dette à Long Terme | $33.6M | $220.3M | $17.4M | $17.3M | $17.2M | $35.1M | $34.0M | $37.0M |
| Passifs Totaux | $182.3M | $240.9M | $37.6M | $41.9M | $39.7M | $59.5M | $77.0M | $75.2M |
| Réserves | -$189.8M | -$210.5M | -$242.7M | -$291.4M | -$350.3M | -$411.2M | -$467.6M | -$521.6M |
| Capitaux Propres | -$167.3M | -$187.4M | $226.1M | $193.2M | $154.0M | $118.3M | $85.8M | $54.1M |
| Dette Totale | $33.6M | $227.2M | $27.2M | $26.5M | $24.4M | $41.4M | $56.5M | $56.4M |
| Dette Nette | $29.5M | $198.8M | -$204.6M | -$153.6M | -$116.7M | -$75.7M | -$45.0M | -$13.6M |
| Fonds de Roulement | $3.2M | $26.9M | $237.5M | $190.5M | $150.5M | $127.3M | $111.8M | $81.6M |
Santé financière
| Dette / Capitaux propres | 1.43 |
| Ratio de liquidité | 4.32 |
Rentabilité
| Rentabilité des capitaux propres | -96.66% |
| Rentabilité du capital investi | -48.39% |
| Rentabilité des actifs | -41.94% |
| Marge brute | 77.06% |
| Marge opérationnelle | -52.96% |
| Marge nette | -55.03% |
Entreprises liées: ACRV · ASRT · EDAP · HYPR · IMUX · PMVP · RLMD
Explorer le secteur: Healthcare · Medical - Devices
Plus de sections de LUNG: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions